This site is intended for U.S. healthcare professionals.

Visit Pfizer Medical



Sign InLog Out ProductsOrderMaterialsCo-pay Cards & Patient Savings OffersRequest SamplesHospital ProductsVaccinesPatient AssistancePfizer Oncology TogetherPfizer RxPathwaysExplore ContentEventsMaterialsVideosContact



Lung Cancer

Lung cancer is the number 1 killer among cancers worldwide.1 According to The World Health Organization (WHO), lung cancer causes 1.59 million deaths a year globally.2 There are 2 main types of lung cancer: small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC).1 NSCLC accounts for 80% to 90% of lung cancers.2 Treatment for NSCLC is rapidly evolving and increasingly becoming biomarker-driven.3


Browse and register for speaker programs


View materials for you and your patients


Find videos and on-demand webinars


SEER Cancer Stat Facts: Lung and Bronchus Cancer. National Cancer Institute. Bethesda, MD. Accessed October 19, 2022. D, Popat S, Kerr K, et al. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [published correction appears in Ann Oncol. 2019;30(5):863-870]. Ann Oncol. 2018;29(Suppl 4):iv192-iv237.Kerr KM, Bibeau F, Thunnissen E, et al. The evolving landscape of biomarker testing for non-small cell lung cancer in Europe. Lung Cancer. 2021;154:161-175.

To report an adverse event, please call 1-800-438-1985

Pfizer for Professionals 1-800-505-4426

This site is intended only for U.S. healthcare professionals. The products discussed in this site may have different product labeling in different countries. The information provided is for educational purposes only.

© 2024 Pfizer Inc. All rights reserved.

You are now leaving Pfizer  You are now leaving a Pfizer operated website. Links to all outside sites are provided as a resource to our visitors. Pfizer accepts no responsibility for the content of sites that are not owned and operated by Pfizer.